Supreme Court Explains that Comprehensive Motor Insurance Covers Occupants of a Vehicle || Supreme Court: Judgments Operate Retrospectively Unless Made Prospective || Supreme Court Clarifies Principles Governing Witness Recall under Order 18 Rule 17 of CPC || Gujarat High Court: Res Judicata Prevents Trustees from Reopening Trust Property Disputes || Allahabad HC: Trial Courts Cannot Examine Witnesses to Generate Fresh Evidence Before Cognizance || Rajasthan HC: Funds Collected From an Illegal Toll Plaza Must Be Used For Tree Plantation || Delhi HC: Minor’s Signature Alone Cannot Establish Consent for Pregnancy Termination || Karnataka HC Allows ECIR Challenge under Article 226, Rejects ED’s Immunity Claim || Allahabad High Court Upholds Transfer of a Dissolved Society's Assets to its Successor Company || P&H HC: Cheque Bounce Cases Remain Compoundable Even After Appellate Courts Uphold Conviction

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :